Underreporting high-risk prescribing among Medicare Advantage plans: a cross-sectional analysis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 24081286.
- Also identified by DOI 10.7326/0003-4819-159-7-201310010-00005 and PMC identifier 4720729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although Medicare Advantage plans are required to report clinical performance using Healthcare Effectiveness Data and Information Set (HEDIS) quality indicators, the accuracy of plan-reported performance rates is unknown. To compare calculated and reported rates of high-risk prescribing among Medicare Advantage plans. Cross-sectional comparison. 172 Medicare Advantage plans. A random sample of beneficiaries in 172 Medicare Advantage plans in 2006 (n = 177,227) and 2007 (n = 173,655). Plan-reported HEDIS rates of high-risk prescribing among elderly persons were compared with rates calculated from Medicare Advantage plans' Part D claims by using the same measure specifications and source population. The mean rate of high-risk prescribing derived from Part D claims was 26.9% (95% CI, 25.9% to 28.0%), whereas the mean plan-reported rate was 21.1% (CI, 20.0% to 22.3%). Approximately 95% of plans underreported rates of high-risk prescribing relative to calculated rates derived from Part D claims. The differences in the calculated and reported rates negatively affected quality rankings for the plans that most accurately reported rates. For example, the 9 plans that reported rates of high-risk prescribing within 1 percentage point of calculated rates were ranked 43.4 positions lower when reported rates were used instead of calculated rates. Among 103,680 individuals present in both the sample of Part D claims and HEDIS data in 2006, Medicare Advantage plans incorrectly excluded 10.3% as ineligible for the HEDIS high-risk prescribing measure. Among those correctly included in the high-risk prescribing denominator, the reported rate of high-risk prescribing was 21.9% and the calculated rate was 26.2%. A single quality measure was assessed. Medicare Advantage plans underreport rates of high-risk prescribing, suggesting a role for routine audits to ensure the validity of publicly reported quality measures. Health Assessment Lab and National Institute on Aging.
Medical subject headings
- Drug Prescriptions
- Mandatory Reporting
- Medicare Part C